Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer. (Record no. 27798974)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01499 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517184840.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201909s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1029-2330 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1080/1061186X.2017.1405427 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Greish, Khaled |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190930 |
245 00 - TITLE STATEMENT | |
Title | Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of drug targeting |
Date of publication, distribution, etc. | 08 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 610-615 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibiotics, Antineoplastic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Models, Animal |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Delivery Systems |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mammary Neoplasms, Experimental |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanoparticles |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphodiesterase 5 Inhibitors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sildenafil Citrate |
General subdivision | pharmacology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fateel, Maryam |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abdelghany, Sara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rachel, Nanitha |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alimoradi, Houman |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bakhiet, Moiz |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alsaie, Ahmed |
773 0# - HOST ITEM ENTRY | |
Title | Journal of drug targeting |
Related parts | vol. 26 |
-- | no. 7 |
-- | p. 610-615 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1080/1061186X.2017.1405427">https://doi.org/10.1080/1061186X.2017.1405427</a> |
Public note | Available from publisher's website |
No items available.